Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma. | Blood Cancer J | 2025 | 40759639 | PubTator, text mining | PubMed |
| Deciphering enemy tactics - the narrow path to an optimal anti-cancer strategy targeting the Warburg effect. | Pharmacol Rep | 2025 | 40750753 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Lactate Prevents Glucose Deprivation-Induced Parthanatos in Gastric Cancer Cells Through Alleviating Intracellular Reactive Oxygen Species. | Cell Biol Int | 2025 | 40745690 | PubTator, text mining | PubMed |
| Comprehensive insight on immune landscape in intracerebral hemorrhage patients with single-cell RNA sequencing: from blood to hematoma. | J Neuroinflammation | 2025 | 40739271 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis of in vivo and in vitro human pancreas development. | Genes Dis | 2025 | 40735693 | PubTator, text mining | PubMed |
| Clinical application prospects of traditional Chinese medicine as adjuvant therapy for metabolic reprogramming in colorectal cancer. | Front Immunol | 2025 | 40735327 | PubTator, text mining | PubMed |
| Flipping the Target: Evaluating Natural LDHA Inhibitors for Selective LDHB Modulation. | Molecules | 2025 | 40733189 | PubTator, text mining | PubMed |
| Effects of 4-hydroxyphenylacetic acid, a phenolic acid compound from Yucca schidigera extract, on immune function and intestinal health in meat pigeons. | Poult Sci | 2025 | 40701007 | PubTator, text mining | PubMed |
| Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis. | Research (Wash D C) | 2025 | 40698330 | PubTator, text mining | PubMed |
| Exploration of biomarkers associated with histone lactylation modification in spinal cord injury. | Front Genet | 2025 | 40672388 | PubTator, text mining | PubMed |
| Histone lactylation-driven YTHDF2 promotes non-small cell lung cancer cell glycolysis and stemness by recognizing m6A modification of SFRP2. | Biochem Pharmacol | 2025 | 40619016 | PubTator, text mining | PubMed |
| Multiplex Cardiac Biomarker Profiling for Precision Coronary Artery Disease Risk Assessment Using SERS with Cubic Core-Satellite Nanostructures. | Anal Chem | 2025 | 40580100 | PubTator, text mining | PubMed |
| Editor's Note: Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis. | Cancer Res | 2025 | 40518801 | PubTator, text mining | PubMed |
| Lactate Is a Major Promotor of Breast Cancer Cell Aggressiveness. | Cancers (Basel) | 2025 | 40507273 | PubTator, text mining | PubMed |
| Response to Suresh et al. | EMBO J | 2025 | 40500329 | PubTator, text mining | PubMed |
| Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MS. | Skelet Muscle | 2025 | 40483507 | PubTator, text mining | PubMed |
| Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8+ T cells. | Nat Cell Biol | 2025 | 40461882 | PubTator, text mining | PubMed |
| Salivary Extracellular Vesicles in Detection of Head and Neck Cancers: A Systematic Review. | Int J Nanomedicine | 2025 | 40452788 | PubTator, text mining | PubMed |
| Pilot study of canakinumab (Ilaris) in steroid naïve children with Duchenne muscular dystrophy demonstrates safety and exploratory changes in potential serum protein response biomarkers. | J Neuromuscul Dis | 2025 | 40396427 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=7